Abstract
Adenosine inhibits S-91 melanoma membrane adenylate cyclase. This inhibition is observed with all activators tested; α-melanocyte-stimulating hormone, [norleucine4]α-melanocyte-stimulating hormone, prostaglandin-E2, and fluoride ion. This inhibition is also observed with the ribose modified adenosine analog adenine-9-β-d-arabinofuranoside. However, "R" site (stringent for the ribose moiety) analogs such as 2-chloroadenosine and 6-methyladenosine were without effect. Addition of manganous ion (Mn2+), a potent activator of adenylate cyclase, markedly enhances the inhibition by adenosine. The nucleoside specificity, Mn2+ requirement, and lack of reversal by the potent R-site antagonist, 3-isobutyl-1-methylxanthine, suggest that the S-91 melanoma membrane adenylate cyclase system contains only P-type (stringent for purine moiety) receptor sites.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-7 |
| Number of pages | 7 |
| Journal | Archives of Biochemistry and Biophysics |
| Volume | 201 |
| Issue number | 1 |
| DOIs | |
| State | Published - Apr 15 1980 |
ASJC Scopus subject areas
- Biophysics
- Biochemistry
- Molecular Biology
Fingerprint
Dive into the research topics of 'Adenosine and divalent cation effects on S-91 melanoma adenylate cyclase'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS